BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 26332104)

  • 1. Postoperative nomogram for predicting disease-specific death and recurrence in papillary thyroid carcinoma.
    Lang BH; Wong CK; Yu HW; Lee KE
    Head Neck; 2016 Apr; 38 Suppl 1():E1256-63. PubMed ID: 26332104
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validation and Comparison of Nomograms in Predicting Disease-Specific Survival for Papillary Thyroid Carcinoma.
    Lang BH; Wong CK
    World J Surg; 2015 Aug; 39(8):1951-8. PubMed ID: 25809064
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A nomogram predicting contralateral central neck lymph node metastasis for papillary thyroid carcinoma.
    Hei H; Song Y; Qin J
    J Surg Oncol; 2016 Nov; 114(6):703-707. PubMed ID: 27634154
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nomogram for predicting central node metastasis in papillary thyroid carcinoma.
    Kim SK; Chai YJ; Park I; Woo JW; Lee JH; Lee KE; Choe JH; Kim JH; Kim JS
    J Surg Oncol; 2017 Mar; 115(3):266-272. PubMed ID: 27859312
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integrated analysis identifying new lncRNA markers revealed in ceRNA network for tumor recurrence in papillary thyroid carcinoma and build of nomogram.
    Chen F; Li Z; Deng C; Yan H
    J Cell Biochem; 2019 Dec; 120(12):19673-19683. PubMed ID: 31271223
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nomograms predicting disease-specific regional recurrence and distant recurrence of papillary thyroid carcinoma following partial or total thyroidectomy.
    Ge MH; Cao J; Wang JY; Huang YQ; Lan XB; Yu B; Wen QL; Cai XJ
    Medicine (Baltimore); 2017 Jul; 96(30):e7575. PubMed ID: 28746205
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Nomogram Based on the Characteristics of Metastatic Lymph Nodes to Predict Papillary Thyroid Carcinoma Recurrence.
    Jianyong L; Jinjing Z; Zhihui L; Tao W; Rixiang G; Jingqiang Z
    Thyroid; 2018 Mar; 28(3):301-310. PubMed ID: 29439612
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metastatic lymph node status in the central compartment of papillary thyroid carcinoma: A prognostic factor of locoregional recurrence.
    Park YM; Wang SG; Lee JC; Shin DH; Kim IJ; Son SM; Mun M; Lee BJ
    Head Neck; 2016 Apr; 38 Suppl 1():E1172-6. PubMed ID: 26268535
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic nomograms to predict oncological outcome of thyroid cancers.
    Pathak KA; Mazurat A; Lambert P; Klonisch T; Nason RW
    J Clin Endocrinol Metab; 2013 Dec; 98(12):4768-75. PubMed ID: 24152685
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and validation of a nomogram for preoperative prediction of level VII nodal spread in papillary thyroid cancer: Radiologic-pathologic correlation.
    Li S; Yun M; Hong G; Tian L; Yang A; Liu L
    Surg Oncol; 2021 Jun; 37():101520. PubMed ID: 33486344
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic Scores for Predicting Recurrence in Patients with Differentiated Thyroid Cancer.
    Somboonporn C
    Asian Pac J Cancer Prev; 2016; 17(5):2369-74. PubMed ID: 27268599
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Postoperative recurrence of papillary thyroid carcinoma with lymph node metastasis.
    Liu FH; Kuo SF; Hsueh C; Chao TC; Lin JD
    J Surg Oncol; 2015 Aug; 112(2):149-54. PubMed ID: 26175314
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A variation in recurrence patterns of papillary thyroid cancer with disease progression: A long-term follow-up study.
    Lee JH; Chung YS; Lee YD
    Head Neck; 2017 Apr; 39(4):767-771. PubMed ID: 28139038
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Using a nomogram based on preoperative serum fibrinogen levels to predict recurrence of papillary thyroid carcinoma.
    Jianyong L; Zhihui L; Rixiang G; Jingqiang Z
    BMC Cancer; 2018 Apr; 18(1):390. PubMed ID: 29621982
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Risk factors for central neck lymph node metastases of papillary thyroid carcinoma].
    Sun YS; Lyu HJ; Zhao YR; Zhang SS; Bai YX; Shi BY
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2017 Jun; 52(6):421-425. PubMed ID: 28635213
    [No Abstract]   [Full Text] [Related]  

  • 16. A methylomics-associated nomogram predicts recurrence-free survival of thyroid papillary carcinoma.
    Chen H; Ma X; Yang M; Wang M; Li L; Huang T
    Cancer Med; 2020 Oct; 9(19):7183-7193. PubMed ID: 32783399
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Imprinted gene detection effectively improves the diagnostic accuracy for papillary thyroid carcinoma.
    Chen Y; Yin M; Zhang Y; Zhou N; Zhao S; Yin H; Shao J; Min X; Chen B
    BMC Cancer; 2024 Mar; 24(1):359. PubMed ID: 38509485
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High recurrent rate of multicentric papillary thyroid carcinoma.
    Lin JD; Chao TC; Hsueh C; Kuo SF
    Ann Surg Oncol; 2009 Sep; 16(9):2609-16. PubMed ID: 19533244
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Population-based study evaluating and predicting the probability of death resulting from thyroid cancer and other causes among patients with thyroid cancer.
    Yang L; Shen W; Sakamoto N
    J Clin Oncol; 2013 Feb; 31(4):468-74. PubMed ID: 23270002
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nomogram for predicting central lymph node metastasis in papillary thyroid microcarcinoma: A retrospective cohort study of 8668 patients.
    Wang Y; Guan Q; Xiang J
    Int J Surg; 2018 Jul; 55():98-102. PubMed ID: 29803769
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.